Skip to main content
Make Data Work
Oct 15–17, 2014 • New York, NY

Accelerating Parkinson’s Research with Big Data Technologies

Ron Kasabian (Intel)
9:30am–9:35am Thursday, 10/16/2014
Keynotes, Sponsored
Location: 1D
Average rating: ***..
(3.42, 52 ratings)

New drug development can take anywhere from 15-30 years and cost over $1B from the start of basic research through the end of clinical trials. With an annual expenditure of $100B per year on research and an average success rate of only 1 out of 12 new treatments reaching end patients, substantial opportunities exist for improving the efficiency of this process and overall patient care.

This talk introduces how Intel is working with scientists and physicians to help improve research, treatment, and drug development for Parkinson’s Disease using data science and enabling the Parkinson’s research community to build upon an open platform for big data analytics

This talk is sponsored by Intel

Photo of Ron Kasabian

Ron Kasabian

Intel

Ron Kasabian
VP and General Manager, Big Data Solutions
Intel Corporation
Ronald.e.kasabian@intel.com
Extended bio link: http://download.intel.com/newsroom/kits/datacenter/pdfs/Ron_Kasabian_Bio.pdf